Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment

Scandinavian Journal of Rheumatology

Volumn 31, Issue 1, 2002, Pages 44-45

  Mayordomo, Lucia ^a   Marenco, Jose Luis ^a   Gomez Mateos, Jesus ^a   Rejon, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Anti TNF alpha; Inflammatory bowel disease; Infliximab; Miliary tuberculosis; Rheumatoid arthritis

Indexed keywords

INFLIXIMAB; ISONIAZID; METHOTREXATE; PREDNISOLONE; PYRAZINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; ENTERITIS; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MILIARY TUBERCULOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TREATMENT PLANNING;

ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG; MYCOBACTERIUM TUBERCULOSIS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, MILIARY; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036181410     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097402317255372     Document Type: Article

References (15)

1. Infliximab (chimeric anti-tumour necrosis factor (monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
2. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor (monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
3. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate theraphy
4. Infliximab and methotrexate in the treatment of Rheumatoid Arthritis
5. Infliximab: A review of its use in the management of rheumatoid arthritis
6. Reactivation tuberculosis in a patient with anti-TNF-alpha treatment
7. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent
8. Cytokine pathways and joint inflammation in rheumatoid arthritis
9. Anti-tumor necrosis factor-α therapy of rheumatoid arthritis
10. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80kDa tumor necrosis factor receptor
11. Differential effects of TNF and LTalpha in the host defense against M. bovis BCG
12. Tumor necrosis factor receptor 2 plays a minor role for mycobacterial immunity
13. Lethal granuloma disintegration in mycobacteria-infected TNFRp55-/- mice is dependent on T cells and IL-12
14. High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: Synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas
15. New comparisons of two types of TNFα antagonists approved for rheumatoid arthritis